Cargando…
Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma
Progesterone therapy is an effective treatment for atypical endometrial hyperplasia and early endometrial carcinoma (EC). However, progesterone resistance is the main obstacle to the success of conservative treatment in women with type I EC and remains a major clinical challenge. Studies indicate th...
Autor principal: | Shao, Ruijin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869473/ https://www.ncbi.nlm.nih.gov/pubmed/24386010 http://dx.doi.org/10.3332/ecancer.2013.381 |
Ejemplares similares
-
Endometrial progesterone resistance and PCOS
por: Li, Xin, et al.
Publicado: (2014) -
Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
por: Kreizman-Shefer, Hila, et al.
Publicado: (2014) -
Progesterone through Progesterone Receptor B Isoform Promotes Rodent Embryonic Oligodendrogenesis
por: González-Orozco, Juan Carlos, et al.
Publicado: (2020) -
Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression
por: Grindstad, Thea, et al.
Publicado: (2018) -
Isoform specificity of progesterone receptor antibodies
por: Fabris, Victoria, et al.
Publicado: (2017)